Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide
- PMID: 11757771
- DOI: 10.2169/internalmedicine.40.1136
Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide
Abstract
We report a patient with an initial relapse of acute promyelocytic leukemia (APL) who achieved a second complete remission (CR) after treatment with arsenic trioxide. The patient, a 66-year-old woman diagnosed as having relapsed APL, received arsenic trioxide intravenously at a dose of 10 mg/day. At day 36, the patient achieved a second CR. The side effects were slight neuralgia and mild skin erythematous changes, which improved following cessation of the drug. Although arsenic trioxide may be effective for relapsed APL, it should be used with caution because of various complications.
Similar articles
-
[Successful treatment after acute promyelocytic leukemia (APL) syndrome of relapsed API with arsenic trioxide].Gan To Kagaku Ryoho. 2003 Mar;30(3):431-4. Gan To Kagaku Ryoho. 2003. PMID: 12669407 Japanese.
-
Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia.Ann Hematol. 1999 Jul;78(7):329-32. doi: 10.1007/s002770050523. Ann Hematol. 1999. PMID: 10466445
-
Anti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia.Leuk Lymphoma. 2006 Jan;47(1):81-8. doi: 10.1080/10428190500300373. Leuk Lymphoma. 2006. PMID: 16321832 Clinical Trial.
-
Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia.Oncologist. 2001;6 Suppl 2:11-6. doi: 10.1634/theoncologist.6-suppl_2-11. Oncologist. 2001. PMID: 11331435 Review.
-
Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.Leuk Lymphoma. 2000 Jul;38(3-4):283-93. doi: 10.3109/10428190009087019. Leuk Lymphoma. 2000. PMID: 10830735 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources